(palbociclib)
IBRANCE is supplied in the following strengths and package configurations:
| Package Configuration | Tablet Strength (mg) | NDC | Tablet Description |
|---|---|---|---|
Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) | 125 | NDC 0069-0688-03 | Oval, light purple, film-coated tablets debossed with "Pfizer" on one side and "PBC 125" on the other side. |
Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) | 100 | NDC 0069-0486-03 | Oval, green, film-coated tablets debossed with "Pfizer" on one side and "PBC 100" on the other side. |
Monthly box containing 3 weekly blister packs of 7 tablets each (21 tablets total) | 75 | NDC 0069-0284-03 | Round, light purple, film-coated tablets debossed with "Pfizer" on one side and "PBC 75" on the other side. |
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.